Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

NICOX SA.

(COX)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur NICOX SA.
17/11Nicox is Granted Patent for Blepharitis Product Candidate NCX 4251 in Europe
10/11Nicox's NCX 470 Dolomites Phase 2 Results in Glaucoma Patients to be Presented at the A..
10/11Nicox?s NCX 470 Dolomites Phase 2 Results in Glaucoma Patients to be Presented at the A..
02/11Number of voting rightts as of October 31
19/10NICOX : Provides Third Quarter 2021 Business and Financial Highlights
13/10NICOX : to present at the OIS Glaucoma Virtual Innovation Showcase
04/10NICOX : Launches New Corporate & Investor Website
29/09NICOX : Eye Drug Shows Retinal Cell Protection In Nonclinical Trial
29/09NICOX : NCX 470 Shows Retinal Cell Protection in a Nonclinical Model
29/09Nicox SA Reports New Data on NCX 470 in Nonclinical Model of Retinal Cell Damage Induce..
27/09GLOBAL MARKETS LIVE : Intel, Apple, Rolls-Royce, Raytheon, MGM...
27/09NICOX : First Half 2021 Financial Results and Business Update
27/09Nicox S.A. Announces Retirement of José Boyer as Interim Head of R&D
27/09Nicox S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
23/09GLOBAL MARKETS LIVE : Valneva,Boeing, Facebook, Kubota, Otis...
23/09NICOX : Eye Drug Trial Fails To Meet Efficacy Endpoints
23/09NICOX : Announces Results from the NCX 4251 Phase 2b Mississippi Blepharitis Trial
23/09Nicox S.A. Announces Results from the NCX 4251 Phase 2B Mississippi Blepharitis Trial
16/07GLOBAL MARKETS LIVE : Intel, Moderna, Burberry, Pfizer, SoftwareOne, Swisscom...
16/07EN DIRECTO DESDE LOS MERCADOS : Rio Tinto, Pfizer, Intel, Moderna, Burberry, Ericsson, Pum..
16/07NICOX : Provides Second Quarter 2021 Business and Financial Highlights and Strategic Updat..
13/07NICOX : Appoints Robert N. Weinreb, M.D. and Sanjay G. Asrani, M.D. to its Glaucoma Clinic..
13/07Nicox Appoints Robert N. Weinreb, M.D. and Sanjay G. Asrani, M.D. to Its Glaucoma Clini..
06/07NICOX : Half-year liquidity contract statement with Kepler Cheuvreux
05/07GLOBAL MARKETS LIVE : WM Morrison, IBM, Didi...
05/07NICOX : to Get $2 Million from Ocumension Under Amended Zerviate License Deal
05/07EN DIRECTO DESDE LOS MERCADOS : Repsol, Holcim, Spartoo, WM Morrison, Didi, Aeropuerto de ..
05/07NICOX : to Receive $2 Million from Ocumension Therapeutics as Advance Milestone Payment un..
05/07Nicox SA Amends its March 2019 License Agreement with Ocumension Therapeutics
02/07NICOX : Completes Treatment Phase of Mid-Stage Trial for Eye Drug
02/07NICOX : Announces Last Patient Completed NCX 4251 Mississippi Phase 2b Blepharitis Trial
02/07Nicox Announces Last Patient Completed NCX 4251 Mississippi Phase 2B Blepharitis Trial
02/07NICOX S.A.(ENXTPA : COX) dropped from Next Biotech Index
01/07GLOBAL MARKETS LIVE : Amazon, The Gap, Fod, Lockheed Martin, CureVac...
01/07Nicox's NCX 470 Demonstrates Significant Intraocular Pressure Lowering in Dolomites Pha..
01/07Nicox SA Presented Results from the Dolomites Phase 2 Clinical Trial Showing That NCX 4..
25/06NICOX : Licensee Bausch + Lomb Secures Regulatory Approval for Vyzulta in UAE
25/06GLOBAL MARKETS LIVE : Facebook, Toshiba, Fedex, Nike, Microsoft...
25/06NICOX : Licensee Bausch + Lomb Receives Approval for VYZULTA® (latanoprostene bunod ophtha..
25/06Nicox’s Licensee Bausch + Lomb Receives Approval for VYZULTA® (latanoprostene bunod oph..
24/06GLOBAL MARKETS LIVE : Siemens, BHP Group, Visa, JP Morgan Chase, Proximus...
23/06NICOX : NCX 470 Dolomites Phase 2 Results in Glaucoma Patients To Be Presented at the Worl..
23/06Nicox SA to Present NCX 470 Dolomites Phase 2 Results in Glaucoma Patients at the Worl..
01/06NICOX : Completes Patient Enrollment In Mid-Stage Study Of Eye Drug
01/06Londres y Nueva York vuelven al juego
01/06EN DIRECTO DESDE LOS MERCADOS : Axa, Daimler, Airbus, Nokia, Nacon, Volkswagen, Aryzta...
01/06NICOX : Completes Pre-Defined Enrollment of NCX 4251 Mississippi Phase 2b Blepharitis Tria..
01/06Nicox's Completes Pre-Defined Enrollment of NCX 4251 Mississippi Phase 2b Blepharitis T..
05/05GLOBAL MARKETS LIVE : Lyft, Activision, General Electric...
05/05El gusto de los ídolos
05/05EN DIRECTO DESDE LOS MERCADOS : Nestlé, Stellantis, Novartis, Boeing, Daimler, AXA, Nissan..
05/05NICOX : partners with Laboratorios Grin to bring ZERVIATE to Mexico
05/05Nicox Partners with Laboratorios Grin to Bring Zerviate to Mexico
04/05Nicox's Eye Drug Vyzulta Gets Qatar Nod, Launched in Taiwan
04/05NICOX : Licensee Bausch + Lomb Launches VYZULTA® (latanoprostene bunod ophthalmic solution..
04/05NICOX : Licensee Bausch + Lomb Launches VYZULTA® (latanoprostene bunod ophthalmic solution..
04/05Nicox’s Licensee Bausch + Lomb Launches VYZULTA® (Latanoprostene Bunod Ophthalmic Solut..
30/04No hay grandes sorpresas en abril para los mercados
30/04Nicox Updates on Fera Pharmaceuticals
27/04NICOX : Gets Notice of Allowance in US Patent Application for Eye Drug
27/04U.S. Patent Office Issues Notice of Allowance for Nicox’s Latanoprostene Bunod in Norma..
23/04GLOBAL MARKETS LIVE : Honeywell, American Express, Intel...
23/04NICOX : NCX 4251 Mississippi Phase 2b Blepharitis Trial Reaches 50% Enrollment
23/04Nicox’s NCX 4251 Mississippi Phase 2B Blepharitis Trial Reaches 50% Enrollment
22/04U.S. Patents for Nicox's Latanoprostene Bunod, Commercialized as VYZULTA®, Eligible for..
22/04U.S. Patents for Nicox’s Latanoprostene Bunod, Commercialized as VYZULTA®, Eligible for..
19/04BAUSCH HEALTH : Announces VYZULTA (latanoprostene bunod ophthalmic solution), 0.024%, is N..
19/04En la bolsa, ¿los árboles suben al cielo?
19/04EN DIRECTO DESDE LOS MERCADOS : Korian, Daimler, Tesla, Coinbase, ABM Amro, Juventus, Rena..
19/04NICOX : Provides First Quarter 2021 Business Update and Financial Highlights
19/04Nicox S.A. Announces Key Expected Value-Inflection Milestones
19/04Nicox S.A. Reports Revenue Results for the First Quarter of 2021
16/04GLOBAL MARKETS LIVE : Daimler, GSK, Mattel
16/04El crecimiento chino se invita a sí mismo a la casa de las brujas
16/04EN DIRECTO DESDE LOS MERCADOS : L\'Oréal, HelloFresh, Daimler, GSK, Scor, Thermo Fisher, A..
1  2  3  4  5  6  7Suiv.